Novartis research leader takes the helm at Forty Seven, a CIRM-backed fledgling already deep in the clinic
Menlo Park, CA-based Forty Seven launched well ahead of the game compared to most any other biotech upstart. When the company was spun out of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
